Details for New Drug Application (NDA): 022571
✉ Email this page to a colleague
The generic ingredient in CUVPOSA is glycopyrrolate. There are seventeen drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
Summary for 022571
Tradename: | CUVPOSA |
Applicant: | Merz Pharms |
Ingredient: | glycopyrrolate |
Patents: | 0 |
Pharmacology for NDA: 022571
Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for 022571
Suppliers and Packaging for NDA: 022571
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571 | NDA | Merz Pharmaceuticals, LLC | 0259-0501 | 0259-0501-16 | 1 BOTTLE in 1 CARTON (0259-0501-16) / 473 mL in 1 BOTTLE |
CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571 | NDA AUTHORIZED GENERIC | Merz Pharmaceuticals, LLC | 0259-0502 | 0259-0502-16 | 1 BOTTLE in 1 CARTON (0259-0502-16) / 473 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 1MG/5ML | ||||
Approval Date: | Jul 28, 2010 | TE: | AA | RLD: | Yes |
Expired US Patents for NDA 022571
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merz Pharms | CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571-001 | Jul 28, 2010 | 7,638,552 | ⤷ Subscribe |
Merz Pharms | CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571-001 | Jul 28, 2010 | 7,816,396 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription